PlumX Metrics
Embed PlumX Metrics

Anti-inflammatory effects of siponimod on astrocytes

Neuroscience Research, ISSN: 0168-0102, Vol: 184, Page: 38-46
2022
  • 4
    Citations
  • 0
    Usage
  • 11
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

Studies from Yokohama City University Reveal New Findings on Life Science (Anti-inflammatory Effects of Siponimod On Astrocytes)

2022 NOV 04 (NewsRx) -- By a News Reporter-Staff News Editor at Japan Daily Report -- Investigators discuss new findings in Life Science. According to

Article Description

Siponimod, which is approved to treat active secondary progressive multiple sclerosis, acts as a functional antagonist of sphingosine-1-phosphate (S1P) receptor 1 (S1P 1 ) and an agonist of S1P 5. S1P 1 antagonization, which inhibits lymphocyte egress from lymphoid tissues and subsequent infiltration into the central nervous system (CNS), is considered the main therapeutic mechanism of siponimod. In addition, siponimod’s direct effects on CNS glial cells are another potential neuroprotective mechanism because siponimod can penetrate the blood–brain barrier and CNS glial cells express S1P receptors. However, it remains uncertain whether siponimod directly affects CNS glial cells. In this study, we investigated siponimod’s effects on astrocytes using mouse primary cultures. Siponimod suppressed nuclear factor kappa B activation and pro-inflammatory cytokine production. Using antagonists for S1P 1 and S1P 5, we found that siponimod partially exerts its anti-inflammatory effects via S1P 1, but not via S1P 5. Moreover, siponimod also inhibited histone deacetylase, suggesting that siponimod exerts broad anti-inflammatory effects via S1P 1 antagonization and histone deacetylase inhibition. Siponimod might suppress disease progression in multiple sclerosis in part via direct inhibition of astroglial CNS neuroinflammation.

Bibliographic Details

Ogasawara, Akihiro; Takeuchi, Hideyuki; Komiya, Hiroyasu; Ogawa, Yuki; Nishimura, Koki; Kubota, Shun; Hashiguchi, Shunta; Takahashi, Keita; Kunii, Misako; Tanaka, Kenichi; Tada, Mikiko; Doi, Hiroshi; Tanaka, Fumiaki

Elsevier BV

Neuroscience

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know